TPO regulates nearly all stages of the megakaryocyte (MK) differentiation, and this explains that numerous diseases characterized by an alteration in MK/platelet production leading to thrombocytopenia or thrombocytosis are due to either acquired or hereditary mutations in MPL, THPO, or JAK2. This evidence concerns the gene JAK2 and Thrombocytopenia.